Senator Investment Group LP Vertex Pharmaceuticals Inc Transaction History

Senator Investment Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $89.9 Million - $112 Million	-450,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $8.34 Million - $11.2 Million	-50,000 Reduced 10.0%	450,000 $98.5 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $8.31 Million - $9.35 Million	50,000 Added 11.11%	500,000 $84.7 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $74.1 Million - $85.7 Million	450,000 New	450,000 $82.5 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $65.5 Million - $77.9 Million	-400,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $26.6 Million - $33.6 Million	-175,000 Reduced 30.43%	400,000 $66.3 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $24.3 Million - $27.9 Million	-145,000 Reduced 20.14%	575,000 $111 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $46.7 Million - $54.5 Million	320,483 Added 80.22%	720,000 $122 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $60.6 Million - $70.8 Million	399,517 New	399,517 $65.1 Million

1,717

222M

1.5M

1.31M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.